News

Public · Published

Canaccord Genuity maintains EverQuote at Buy, raises price target to $32 from $28

Canaccord Genuity kept a Buy rating on EverQuote and raised its price target to $32 from $28, up 14.3%. The new target implies 31.9% upside from the Nov 2 close of $24.27.

Published:

Updated:

What happened

Canaccord Genuity kept a Buy rating on EverQuote and raised its price target to $32 from $28, up 14.3%. The new target implies 31.9% upside from the Nov 2 close of $24.27.

Confirmed

Global impact / market context

A higher price target signals the analyst expects more value from the company's online insurance marketplace, which connects shoppers with insurers. That can support investor demand for the shares if results back it up, while the implied gain depends on the stock staying near its last close.

Analyst inference

Price targets are analyst forecasts, not guarantees, and a Buy rating expresses a positive view. EverQuote earns money from insurance referrals, so regulatory and advertising cost changes in that market can affect revenue and profit, making the analyst's higher target a view that still needs confirmation.

Analyst inference

What to watch

  1. EverQuote's stock price versus the Nov 2 close of $24.27, since the $32 target's 31.9% upside is measured from that level. Confirmed
  2. Future EverQuote results, especially revenue from insurer referrals and marketing costs, will test whether the raised target holds or gets revised. Analyst inference
  3. Watch for other analysts changing EverQuote ratings or targets, which could show whether the bullish view is spreading or staying isolated. Proposed

Evidence

  • Original source link unavailable